Abstract
The present invention relates to the use of compositions comprising 4-hydroxyphenyllactic acid for the prevention and/or treatment of IgE-mediated diseases.
| Original language | English |
|---|---|
| IPC | A61P 37/ 08 A I |
| Patent number | WO2025158027 |
| Filing date | 24/01/2025 |
| Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 26/01/2024 |
| Priority number | EP20240154241 |
| Publication status | Published - 2025 |
Fingerprint
Dive into the research topics of '4-hydroxyphenyllactic acid for use in treating and reducing the risk of ige-mediated diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver